These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29407132)

  • 1. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.
    Mitomo S; Jabbour RJ; Watanabe Y; Mangieri A; Ancona M; Regazzoli D; Tanaka A; Nakajima A; Naganuma T; Giannini F; Latib A; Nakamura S; Colombo A
    Int J Cardiol; 2018 Mar; 254():53-58. PubMed ID: 29407132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Mussardo M; Arioli F; Figin F; Piraino D; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2011 Oct; 108(8):1055-60. PubMed ID: 21791332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention.
    Ohashi K; Abe D; Kuroki N; Yuba T; Suzuki K
    Heart Vessels; 2019 Nov; 34(11):1717-1727. PubMed ID: 31028408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry.
    Mitomo S; Jabbour RJ; Mangieri A; Ancona M; Regazzoli D; Tanaka A; Giannini F; Carlino M; Montorfano M; Chieffo A; Latib A; Colombo A
    Int J Cardiol; 2018 Jul; 263():17-23. PubMed ID: 29685691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry.
    Nasu K; Oikawa Y; Habara M; Shirai S; Abe H; Kadotani M; Gotoh R; Hozawa H; Ota H; Suzuki T; Shibata Y; Tanabe M; Nakagawa Y; Serikawa T; Nagasaka S; Takeuchi Y; Fujimoto Y; Tamura H; Kobori Y; Yajima J; Aizawa T; Suzuki T;
    Cardiovasc Interv Ther; 2018 Oct; 33(4):321-327. PubMed ID: 28929334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
    Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
    J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
    Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stent implantation for ostial right coronary artery lesions: five-year outcomes from the j-Cypher registry.
    Ko E; Natsuaki M; Toyofuku M; Morimoto T; Matsumura Y; Oi M; Motohashi Y; Takahashi K; Kawase Y; Tanaka M; Kitada M; Yuzuki Y; Tamura T; Inoue K; Mitsudo K; Kimura T
    Cardiovasc Interv Ther; 2014 Jul; 29(3):200-8. PubMed ID: 24390936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents.
    Gomez-Lara J; Heo JH; Brugaletta S; Garg S; Garcia-Garcia HM; van Geuns RJ; Silber S; Windecker S; Serruys PW
    Am Heart J; 2011 Dec; 162(6):1069-1079.e2. PubMed ID: 22137081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Nakamura S
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions.
    Tsuchida K; Daemen J; Tanimoto S; García-García HM; Kukreja N; Vaina S; Ong AT; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Int J Cardiol; 2008 Oct; 129(3):348-53. PubMed ID: 18031845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.